Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Endokrynologia Polska
MENU
Shortcuts Submit an article Author Guidelines Polish Society of Endocrinology Reviewers 2023 Redeem voucher

open access

Vol 68, No 5 (2017)
Original paper
Submitted: 2016-10-16
Accepted: 2016-12-27
Published online: 2017-07-07
View PDF Download PDF file
Get Citation

Evaluation of vitamin D concentration in a population of young, healthy women — the effects of vitamin D supplementation

Ewa Sewerynek, Karol Cieślak, Małgorzata Janik, Ewelina Gowin, Michał Stuss
DOI: 10.5603/EP.a2017.0042
·
Pubmed: 28879647
·
Endokrynol Pol 2017;68(5):533-540.

open access

Vol 68, No 5 (2017)
Original Paper
Submitted: 2016-10-16
Accepted: 2016-12-27
Published online: 2017-07-07

Abstract

Introduction: The goal of the study was an evaluation of serum vitamin D concentrations in healthy young women.

Material and methods: A total of 106 healthy women, aged 20–30 years, were included in the study. Monthly evaluation — for three months — of the effects of calcium (500 mg) and vitamin D (1500 IU) administration in women with baseline values of vitamin D < 20 ng/mL (Group 1) plus the effects of an 800 IU/d dose in women with the baseline value of D > 20 ng/mL (Group 2). Additionally, calcium and PTH concentrations were assessed at the study onset and after a three-month supplementation. Only 67 women adhered to the prescribed therapeutic regime during the three months of observation.

Results: The mean vitamin D concentration in the entire study group was 16.56 ng/mL, being 12.6 ng/mL in Group 1 and 25.22 ng/mL in Group 2. In the course of vitamin D administration, its concentration increased statistically significantly, both in the entire group and in the subgroups, at all time points compared with the study onset. Moreover, its concentration in the whole population and in Group 1 was significantly higher in each of the time points not only in relation to the baseline, but also in comparison with the results of the previous measurements (after 1 and 2 months of supplementation). In Group 2, vitamin D levels also increased systematically throughout the whole study period, and after 3 months its concentration was significantly higher than after 1 and 2 months. Although there were no differences in calcium concentration after those three months, a statistically significant drop of PTH (p < 0.05) was recorded in the entire population and in Group 1.

Conclusions: A moderate deficiency of vitamin D was observed in the studied population of young women. A supplementation with calcium plus vitamin D brought about an increase of vitamin D concentration as early as in the first month of administration. The optimal concentration of > 30 ng/mL was achieved in Group 1 after three months of vitamin D administration in 1500 IU/d dose.

Abstract

Introduction: The goal of the study was an evaluation of serum vitamin D concentrations in healthy young women.

Material and methods: A total of 106 healthy women, aged 20–30 years, were included in the study. Monthly evaluation — for three months — of the effects of calcium (500 mg) and vitamin D (1500 IU) administration in women with baseline values of vitamin D < 20 ng/mL (Group 1) plus the effects of an 800 IU/d dose in women with the baseline value of D > 20 ng/mL (Group 2). Additionally, calcium and PTH concentrations were assessed at the study onset and after a three-month supplementation. Only 67 women adhered to the prescribed therapeutic regime during the three months of observation.

Results: The mean vitamin D concentration in the entire study group was 16.56 ng/mL, being 12.6 ng/mL in Group 1 and 25.22 ng/mL in Group 2. In the course of vitamin D administration, its concentration increased statistically significantly, both in the entire group and in the subgroups, at all time points compared with the study onset. Moreover, its concentration in the whole population and in Group 1 was significantly higher in each of the time points not only in relation to the baseline, but also in comparison with the results of the previous measurements (after 1 and 2 months of supplementation). In Group 2, vitamin D levels also increased systematically throughout the whole study period, and after 3 months its concentration was significantly higher than after 1 and 2 months. Although there were no differences in calcium concentration after those three months, a statistically significant drop of PTH (p < 0.05) was recorded in the entire population and in Group 1.

Conclusions: A moderate deficiency of vitamin D was observed in the studied population of young women. A supplementation with calcium plus vitamin D brought about an increase of vitamin D concentration as early as in the first month of administration. The optimal concentration of > 30 ng/mL was achieved in Group 1 after three months of vitamin D administration in 1500 IU/d dose.

Full Text:

View PDF Download PDF file
Get Citation

Keywords

vitamin D, supplementation, young women, aged 20–30

About this article
Title

Evaluation of vitamin D concentration in a population of young, healthy women — the effects of vitamin D supplementation

Journal

Endokrynologia Polska

Issue

Vol 68, No 5 (2017)

Article type

Original paper

Pages

533-540

Published online

2017-07-07

Page views

1860

Article views/downloads

1268

DOI

10.5603/EP.a2017.0042

Pubmed

28879647

Bibliographic record

Endokrynol Pol 2017;68(5):533-540.

Keywords

vitamin D
supplementation
young women
aged 20–30

Authors

Ewa Sewerynek
Karol Cieślak
Małgorzata Janik
Ewelina Gowin
Michał Stuss

References (49)
  1. Bone Health and Osteoporosis: A Report of the Surgeon General.: Office of the Surgeon General (US). SourceRockville (MD) 2004.
  2. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7-29, 2000: highlights of the conference. South Med J. 2001; 94(6): 569–573.
    PubMed
  3. Dawson-Hughes B. Calcium insufficiency and fracture risk. Osteoporosis International. 1996; 6(S3): 37–41.
    CrossRef
  4. Bischoff-Ferrari HA, Rees JR, Grau MV, et al. Effect of calcium supplementation on fracture risk: a double-blind randomized controlled trial. Am J Clin Nutr. 2008; 87(6): 1945–1951.
    PubMed
  5. Ross AC, Taylor CL, Yaktine AL, et al. Calcium, Institute of Medicine Committee to Review Dietary Reference Intakes for Calcium and Vitamin D. National Academies Press (US) : 2011.
  6. DeLuca HF. Evolution of our understanding of vitamin D. Nutr Rev. 2008; 66(10 Suppl 2): S73–S87.
    CrossRefPubMed
  7. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357(3): 266–281.
    CrossRefPubMed
  8. Konijeti GG, Arora P, Boylan MR, et al. Vitamin D Supplementation Modulates T Cell-Mediated Immunity in Humans: Results from a Randomized Control Trial. J Clin Endocrinol Metab. 2016; 101(2): 533–538.
    CrossRefPubMed
  9. Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiol Rev. 1998; 78(4): 1193–1231.
    PubMed
  10. Penckofer S, Kouba J, Wallis DE, et al. Vitamin D and diabetes: let the sunshine in. Diabetes Educ. 2008; 34(6): 939–40, 942, 944 passim.
    CrossRefPubMed
  11. Holick MF. Diabetes and the vitamin d connection. Curr Diab Rep. 2008; 8(5): 393–398.
    PubMed
  12. Guessous I, Bochud M, Bonny O, et al. Calcium, vitamin D and cardiovascular disease. Kidney Blood Press Res. 2011; 34(6): 404–417.
    CrossRefPubMed
  13. Pludowski P, Holick MF, Pilz S, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev. 2013; 12(10): 976–989.
    CrossRefPubMed
  14. Bertone-Johnson ER. Vitamin D and the occurrence of depression: causal association or circumstantial evidence? Nutr Rev. 2009; 67(8): 481–492.
    CrossRefPubMed
  15. Chiang M, Natarajan R, Fan X. Vitamin D in schizophrenia: a clinical review. Evid Based Ment Health. 2016; 19(1): 6–9.
    CrossRefPubMed
  16. Clelland JD, Read LL, Drouet V, et al. Vitamin D insufficiency and schizophrenia risk: evaluation of hyperprolinemia as a mediator of association. Schizophr Res. 2014; 156(1): 15–22.
    CrossRefPubMed
  17. Grant WB, Wimalawansa SJ, Holick MF, et al. Emphasizing the health benefits of vitamin D for those with neurodevelopmental disorders and intellectual disabilities. Nutrients. 2015; 7(3): 1538–1564.
    CrossRefPubMed
  18. Holick MF. Vitamin D: physiology, molecular biology and clinical applications. Totowa, New Jersey: Humana Press. ; 1999: 1–16.
  19. Rosen CJ. Clinical practice. Vitamin D insufficiency. N Engl J Med. 2011; 364(3): 248–254.
    CrossRefPubMed
  20. Schoor Nv, Lips P. Worldwide vitamin D status. Best Practice & Research Clinical Endocrinology & Metabolism. 2011; 25(4): 671–680.
    CrossRef
  21. Guessous I, Dudler V, Glatz N, et al. Swiss Survey on Salt Group. Vitamin D levels and associated factors: a population-based study in Switzerland. Swiss Med Wkly. 2012; 142: 0.
    CrossRefPubMed
  22. Płudowski P, Konstantynowicz J, Jaworski M, et al. Standardy Med Pediatria. 2014; 11: 609–617.
  23. Kmieć P, Żmijewski M, Lizakowska-Kmieć M, et al. Widespread vitamin D deficiency among adults from northern Poland (54°N) after months of low and high natural UVB radiation. Endokrynol Pol. 2015; 66(1): 30–38.
    CrossRefPubMed
  24. Kmieć P, Żmijewski M, Waszak P, et al. Vitamin D deficiency during winter months among an adult, predominantly urban, population in Northern Poland. Endokrynol Pol. 2014; 65(2): 105–113.
    CrossRefPubMed
  25. Ganmaa D, Holick MF, Rich-Edwards JW, et al. Vitamin D deficiency in reproductive age Mongolian women: a cross sectional study. J Steroid Biochem Mol Biol. 2014; 139: 1–6.
    CrossRefPubMed
  26. Wilger-Gahche JJ, Bailey RL, Burt VL, et al. Mean daily intake of calcium, folate and vitamin D from dietary supplements and the proportion getting above certain Dietary Reference Intake (DRI) levels, in the U.S. population ages 14 years and older: Third National Health and Nutrition Examination Survey (NHANES III) and NHANES, 1999-2006. The FASEB Journal 2009; 23. ; 341: 7.
  27. Bailey RL, Dodd KW, Goldman JA, et al. Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr. 2010; 140(4): 817–822.
    CrossRefPubMed
  28. Munns CF, Shaw N, Kiely M, et al. Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. J Clin Endocrinol Metab. 2016; 101: 394–415.
  29. Munns CF, Shaw N, Kiely M, et al. Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. Horm Res Paediatr. 2016; 85(2): 83–106.
    CrossRefPubMed
  30. Heaney RP. Calcium and obesity: effect size and clinical relevance. Nutr Rev. 2011; 69(6): 333–334.
    CrossRefPubMed
  31. Sun Z, Wang PP, Roebothan B, et al. Calcium and vitamin D and risk of colorectal cancer: results from a large population-based case-control study in Newfoundland and Labrador and Ontario. Can J Public Health. 2011; 102(5): 382–389.
    PubMed
  32. Mitri J, Dawson-Hughes B, Hu FB, et al. Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr. 2011; 94(2): 486–494.
    CrossRefPubMed
  33. Wang Lu, Manson JE, Buring JE, et al. Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension. 2008; 51(4): 1073–1079.
    CrossRefPubMed
  34. Tamer G, Mesci B, Tamer I, et al. Is vitamin D deficiency an independent risk factor for obesity and abdominal obesity in women? Endokrynol Pol. 2012; 63(3): 196–201.
    PubMed
  35. Garanty-Bogacka B, Syrenicz M, Rać M, et al. Serum 25-hydroxyvitamin D (25-OH-D) in obese adolescents. Endokrynol Pol. 2011; 62(6): 506–511.
    PubMed
  36. Rosen CJ, Adams JS, Bikle DD, et al. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev. 2012; 33(3): 456–492.
    CrossRefPubMed
  37. Bolland MJ, Grey A, Reid IR. Should we prescribe calcium or vitamin D supplements to treat or prevent osteoporosis? Climacteric. 2015; 18(sup2): 22–31.
    CrossRef
  38. Pludowski P, Grant W, Bhattoa H, et al. Vitamin D Status in Central Europe. Int J Endocrinol. 2014; 2014: 1–12.
    CrossRef
  39. Nelson ML, Blum JM, Hollis BW, et al. Supplements of 20 microg/d cholecalciferol optimized serum 25-hydroxyvitamin D concentrations in 80% of premenopausal women in winter. J Nutr. 2009; 139(3): 540–546.
    CrossRefPubMed
  40. Smith SM, Gardner KK, Locke J, et al. Vitamin D supplementation during Antarctic winter. Am J Clin Nutr. 2009; 89(4): 1092–1098.
    CrossRefPubMed
  41. Holick MF, Biancuzzo RM, Chen TC, et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab. 2008; 93(3): 677–681.
    CrossRefPubMed
  42. Biancuzzo RM, Young A, Bibuld D, et al. Fortification of orange juice with vitamin D(2) or vitamin D(3) is as effective as an oral supplement in maintaining vitamin D status in adults. Am J Clin Nutr. 2010; 91(6): 1621–1626.
    CrossRefPubMed
  43. Rajakumar K, Moore CG, Yabes J, et al. Effect of Vitamin D3 Supplementation in Black and in White Children: A Randomized, Placebo-Controlled Trial. J Clin Endocrinol Metab. 2015; 100(8): 3183–3192.
    CrossRefPubMed
  44. Gallagher JC, Jindal PS, Smith LM. Vitamin D supplementation in young White and African American women. J Bone Miner Res. 2014; 29(1): 173–181.
    CrossRefPubMed
  45. Cosman F, Shen V, Morgan D, et al. Biochemical responses of bone metabolism to 1,25-dihydroxyvitamin D administration in black and white women. Osteoporos Int. 2000; 11(3): 271–277.
    CrossRefPubMed
  46. Shieh A, Chun RF, Ma C, et al. Effects of High-Dose Vitamin D2 Versus D3 on Total and Free 25-Hydroxyvitamin D and Markers of Calcium Balance. J Clin Endocrinol Metab. 2016; 101(8): 3070–3078.
    CrossRefPubMed
  47. Gallagher JC, Sai A, Templin T, et al. Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Ann Intern Med. 2012; 156(6): 425–437.
    CrossRefPubMed
  48. Gallagher JC, Peacock M, Yalamanchili V, et al. Effects of vitamin D supplementation in older African American women. J Clin Endocrinol Metab. 2013; 98(3): 1137–1146.
    CrossRefPubMed
  49. Płudowski P, Karczmarewicz E, Bayer M, et al. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol. 2013; 64(4): 319–327.
    PubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl